Clinics in Plastic Surgery, Vol. 39, No. 2, April 2012
ISSN: 0094-1298
doi: 10.1016/j.cps.2012.02.001
Pocket Reinforcement Using Acellular Dermal Matrices in Revisionary Breast Augmentation
Abstract
Revision breast augmentation to treat implant malposition is fraught with challenges. This article focuses on treatment of implant malposition by using acellular dermal matrices (ADMs) with the intent of creating more reliable and accurate results. The article discusses the use of ADMs in patients with breast implant complications such as bottoming out, lateral implant displacement, or synmastia. ADM is a foreign material, thereby adding potential complications to consider.
Keywords
• Implant malposition • Bottoming out • Synmastia • Lateral implant malposition • Implant problems • asymmetry • Acellular dermal matrix • Revisionary breast surgery
In 2010, close to 300,000 breast augmentations were performed in the United States, making this the most commonly performed cosmetic surgery.1 By virtue of the sheer numbers of annual breast augmentations performed, a large market for revisionary augmentation procedures exists. The two most frequently encountered complications of primary breast augmentation are capsular contracture and implant malposition.2 This article focuses on treatment of implant malposition, excluding capsular contracture, by using acellular dermal matrices (ADMs).
Implant malposition may occur in any one (or a combination) of the four breast quadrants.
Superior displacement (high-riding implants) may result from inadequate pocket creation, insufficient release of the pectoralis major muscle, or secondarily as a presentation of capsular contracture (Fig. 1A).
Fig. 1 (A) Implants high in relation to breast tissue. (B) Double-bubble deformity, in which the inframammary fold (IMF) has been violated. (C) Widely spaced implants as a consequence of a wide sternum and round rib cage.
Medial displacement (synmastia) is almost always an iatrogenic consequence resulting from overdissection of the pocket or selection of implants that are too large.
Inferior displacement (bottoming out) is the most common malposition and presents as an elongation between the nipple areolar complex (NAC) and neoinframammary fold. This malposition may lead to stretching of the inferior breast pole skin, compromise of the integrity of the inframammary fold (IMF) structure, or a combination of the two (see Fig. 1B).
Lateral displacement of the implant is, to some degree, normal with submuscular implants, but excessive lateralization (telemastia) can create a wide separation between breasts (see Fig. 1C). Each of these deformities needs to be understood anatomically to institute proper revisionary surgery.
Many challenges face the plastic surgeon when considering revisionary augmentation mammaplasty.3 Patient dissatisfaction with the result of the initial procedure and secondary procedures creates unexpected costs and stress for patients who expected acceptable results with a single procedure. Each successive revision is incrementally more challenging, therefore it is crucial that each attempt at revision is done with as much forethought and planning as possible.
It is important to fully understand the anatomy of the primary augmentation failure to properly diagnose and treat the unsatisfactory outcome. Considerations include (Table 1):
Table 1 Considerations for diagnosis and treatment of unsatisfactory outcomes
Measurement | Normal Dimension | Abnormality |
---|---|---|
Nipple to sternal notch | 17–20 cm | Too long indicates the need for superior repositioning of the NAC |
NAC to IMF | 4–6 cm | Too long indicates the need for a mastopexy to reduce the bottom pole skin or repositioning of the IMF superiorly (for double-bubble deformity) |
Location of IMF | Sixth rib | Too low indicates need to reposition the IMF |
Base width | Variable | Assists with the selection of implants |
The following characteristics of the implants should be evaluated:
When considering revision surgery, it is good practice to review the prior operative reports to learn as much as possible about the initial augmentation (or previous revisions) before undertaking further procedures.
Before discussing treatment options and strategy for revision breast augmentation, it is important to understand how to prevent the unsatisfactory result. There are important anatomic considerations that the plastic surgeon must recognize and carefully manage during primary augmentation:
Revision breast augmentation for deformity has a long history, although ADMs have only been in widespread use in plastic surgery during the last decade. The treatment of breast implant malposition depends largely on the patient’s anatomy, presenting complaints, desired outcome, and anatomic limitations. This article reviews some of the tools available to help surgeons in the treatment of these deformities. The use of ADM is often complimentary.
During the last 10 years, ADMs have found widespread acceptance in breast reconstruction procedures, especially during immediate implant reconstruction. By extending the reach of the pectoralis major muscle, ADM allows for a greater degree of expander fill, which offers the advantages of reducing the initial deformity and maximizing the skin envelope. An excellent cosmetic outcome may be achieved because preserved mastectomy skin is optimized for reconstruction.5 Expanders can be filled more rapidly, resulting in a shorter time from mastectomy to completion of reconstruction. The use of ADM may enable the creation of a submuscular pocket adequate to place a full-sized breast prosthesis, which allows maintenance of a fuller, thicker pectoralis muscle to cover the superior and medial implant poles.6 The use of ADM can also improve soft tissue drapery around devices without resorting to the use of (nonpectoral) muscle or fascial flaps. Total device coverage with the use of combined ADM and pectoralis muscle coverage provides precise control of the pocket dimensions and permits more predictable aesthetic outcomes.7
ADM products were introduced to provide an additional tool for surgeons when faced with clinical scenarios in which autogenous tissues were inadequate. Currently, both human and animal sources are used to create allograft and xenograft ADM, respectively. Although each ADM manufacturer may have different techniques in processing the tissue, there is a common pathway.
Tissue is procured through live or cadaveric donors or animal sources. The epidermal and subcutaneous layers are discarded during the initial procedure. All cells are removed, leaving only an acellularized dermis. The tissue is subsequently treated in either a disinfectant solution or irradiated, then cut to size and packaged (most ADMs are available in various thicknesses, sizes, and shapes). Differences between various ADMs can be seen in their production: some are lyophilized, some radiated, and some freeze dried. In addition, some products may need to be refrigerated and/or rehydrated.
The decision of which ADM to use is often a personal one, because many surgeons prefer a single product line and become comfortable with its performance. Cost is of concern, given that most patients seeking revisionary breast augmentation surgery have already incurred a high expense from the initial procedure, and the surgeon should be conscious of this stressor when offering revision options.8 However, it has been my experience that most patients understand that revisions are more complex than primary surgery and each successive revision typically becomes more challenging. For the patient who has already undergone considerable psychological and financial stress from the unsatisfactory result of the initial operation, obtaining an optimal salvage through revision is of primary importance. Therefore, if the surgeon thinks that using a tool like ADM will make for the best outcome, patients will accept a higher cost.
I prefer Strattice™ (LifeCell Corporation, Branchburg, NJ, USA), derived from porcine tissue, for augmentation revision cases requiring ADM usage because of its predictable performance; specifically, the long-term resistance to stretch. This resistance allows accurate intraoperative visualization of the final result. There is some relaxation, but the repair tends to be robust and there is only a slight degree of repair stretch. In contrast, LifeCell’s human cadaveric product Alloderm tends to relax and creates a greater misrepresentation of the final result. In addition, the price of Strattice™ is among the lowest on the market.
The most common implant malposition is inferolateral displacement. Overdissection during primary implant placement and tissue atrophy over time are the primary causes. The challenge in correction of this deformity is the lack of good quality native tissue to support a repair. Capsular repair alone has a high degree of recurrence and can be unreliable because the capsule relaxes during the recovery period.
I have found that the use of ADM to reinforce the repair is an essential part of producing consistent and long-lasting results. Technically, the procedure I use is:
The use of ADM can provide excellent results in cases of inferior (Fig. 3) and lateral displacement (Figs. 4 and 5).
Fig. 3 (A) Implant malposition and asymmetry after placement of submuscular implants. (B) Result following pocket repair with lateral placement of ADM capsulorraphy.
Treatment of synmastia is particularly challenging. There are a variety of techniques described for repair and, as typically is the case when there are many techniques, none is definitively superior. The goal of synmastia repair is to separate the breast mounds and ensure that the tissue overlying the sternum remains immobile. If the implants are subglandular, then changing planes is usually necessary. If the implants are submuscular, changing to subglandular may be an option. However, I rarely place implants in the subglandular or subfascial space; in the short term, the revision may look acceptable, but my longer-term experience (>5 years) with subglandular implants has shown poor results.
I approach synmastia similarly to the correction of implant bottoming out:
When ADM products are used, the postoperative care is not significantly modified from the normal routine. The manufacturers of almost all ADM strongly suggest using drains around the ADM to reduce the rate of seroma formation.
Most patients are motivated to return to physical training regimens soon after surgery, but they are encouraged to do so with a modified routine. Exercise bicycles, treadmills, and ellipticals are all machines that can be used without invoking the pectoralis muscles. The concern is that, with contraction of the pectoralis muscles, pocket repairs may be disrupted and optimal results sacrificed. Patients understand these limitations and are typically compliant with the postoperative restrictions.
ADM is a foreign material, adding potential complications to consider. Two of the most common complications reported in the literature include infection and seroma.9
Infection is an uncommon sequela following placement of ADM. However, if signs of infection are present, such as redness, fevers, drainage, pain, or swelling, management is often a challenge. The conventional wisdom is to expeditiously remove both the ADM and implant. Then, after eradication of infection with antibiotics and time to soften the surrounding tissue, patients are advised to return in 6 months for replacement of the implants.
In my experience, most patients resist accepting the necessity of implant removal. Occasional success can be achieved with removal of the implants, copious irrigation, and removal of all ADM, and then replacement with new implants in a single operation. However, this is often a costly misadventure and caution is urged if this approach is undertaken.
In normal circumstances, seromas are benign complications. However, the problem is more complex when using ADM. If a seroma forms around an ADM, it often leads to encapsulation of the graft instead of the normal course of integration and vascularization. If the ADM becomes encapsulated, it can not optimally perform its reinforcing function. In addition, a seroma around the ADM increases the probability of infection. When a seroma is present, placement of a seroma catheter drain can adequately treat the problem, but establishing the diagnosis is a challenge. Instead, I have found that placing a drain during surgery, so that it rests on top of the ADM, and leaving it in place for 5 days has eliminated problems with seroma formation.
Case study 1: Implant deformity
This 30-year old mother of 2 had submuscular 330-mL saline implants placed via a periareolar incision 7 years ago. She reported that her deformity was present shortly after surgery but, for various reasons, decided not to embark on early revision (Fig. 6A). Her presenting complaints included dissatisfaction with breast size, desire for increased cleavage, and inferolateral displacement of the implants. Options included upsizing, exchange to silicone gel implants, consideration of right-sided crescent mastopexy, and left implant repositioning with capsulorrhaphy and reinforcement with ADM. In addition, the placement of ADM on the left was considered to provide equal bilateral substrate so the tissues would age similarly.
Technical details:
Case study 2: Bilateral implant malposition
This 43-year old woman presented 8 years after her third revision augmentation, with bilateral implant malposition, left Baker IV capsular contracture, severe asymmetry, and synmastia (Fig. 7A). She desired improved symmetry, treatment of her capsular contraction, slightly larger implants, and correction of synmastia.
Technical details:
ADM products have been shown to be an invaluable resource in revisionary breast augmentation procedures, validated both in the plastic surgery literature as well as in my own experience.8,10,11 It is an ideal soft tissue substitute because of the lack of antigenicity and its ability to become integrated and vascularized into the host. These biologic materials also provide the intraoperative benefit of accurate long-term visualization of results, because ADM are generally resistant to stretch over time (some products more than others). In addition, the material provides strength and consistency that I think are superior to a patient’s native tissue (such as capsular flaps) in providing reliable reinforcement for new implant pocket creation. Although high cost may be a drawback, the overall benefit is worth it because patients can be more assured of a reliable and aesthetically pleasing revision that is preferable to the psychological and financial stress of further revisions. I urge all plastic surgeons to consider this tool in their cosmetic and reconstructive breast practice.
Case study 3: Breast augmentation dissatisfaction
This 32-year old woman presented with generalized dissatisfaction following breast augmentation several years ago (Fig. 8A). She thought that her implants were too far apart, too small, and that her breasts were not attractive.
Technical details:
Postoperative photographs are shown at 6 months (see Fig. 8B).
References
1. American Society of Plastic Surgeons. “2010 cosmetic surgery statistics.” Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2010-statisticss/Overall-Trends/2010-cosmetic-plastic-surgery-minimally-invasive-statistics.pdf. Accessed August 25, 2011.
2. U.D. Khan. Combining muscle-splitting biplane with multilayer capsulorrhaphy for the correction of bottoming down following subglandular augmentation. Eur J Plast Surg. 2010;33:259-269.
3. W.P. Adams, S. Teitelbaum, B.P. Bengston, et al. Breast augmentation roundtable. Plast Reconstr Surg. 2006;118(Suppl 7):175S-187S.
4. S.D. Voice, L.N. Carlsen. Using a capsular flap to correct breast implant malposition. Aesthet Surg J. 2001;21:441-444.
5. H. Sbitany, S. Sandeen, A. Amalfi, et al. Acellular dermis-assisted prosthetic breast reconstruction versus complete submuscular coverage: a head-to-head comparison of outcomes. Plast Reconstr Surg. 2009;124(6):1735-1740.
6. R. Zienowicz, E. Karacaoglu. Implant-based breast reconstruction with allograft. Plast Reconstr Surg. 2007;120:373-381.
7. J. Namnoum. Expander/implant reconstruction with Alloderm: recent experience. Plast Reconstr Surg. 2009;124:387-394.
8. T. Hartzell, A.H. Taghinia, J. Chang, et al. The use of human acellular dermal matrix for the correction of secondary deformities after breast augmentation: results and cost. Plast Reconstr Surg. 2010;126(5):1711-1720.
9. M. Newman, K.A. Swartz, M.C. Samson, et al. The true incidence of near term postoperative complications in prosthetic breast reconstruction utilizing human acellular dermal matrices: a meta-analysis. Aesthetic Plast Surg. 2011;35:100-106.
10. G. Maxwell, A. Gabriel. Use of the acellular dermal matrix in revisionary aesthetic breast surgery. Aesthet Surg J. 2009;29:485-493.
11. S. Spear, M. Seruya, M.W. Clemens, et al. Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities. Plast Reconstr Surg. 2011;127:1047.
Disclosures: The author is a consultant for Mentor Corporation.